Paper646348
Amphotericin B pharmacokinetics in humans.
Atkinson AJ and 1 other. Antimicrob Agents Chemother, 1978. Cited by 215 papers, by iCite.
Cite this record
ConductScience Library. Amphotericin B pharmacokinetics in humans. Papers, record 646348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/646348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Aged | |
| Biological Assay | |
| Humans | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Models, Biological |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 829788 | Plasma and tissue protein binding of drugs in pharmacokinetics. | Drug Metab Rev | 1976 | https://conductscience.org/library/papers/829788 | PubMed |
| 3 | 5394441 | A pharmacologic guide to the clinical use of amphotericin B. | J Infect Dis | 1969 | https://conductscience.org/library/papers/5394441 | PubMed |
| 4 | 4586143 | Amphotericin B therapy in an anephric patient. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4586143 | PubMed |
| 5 | 4823813 | Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. | Ann Intern Med | 1974 | https://conductscience.org/library/papers/4823813 | PubMed |
| 6 | 4423599 | Clearance and biologic half-life as indices of intrinsic hepatic metabolism. | J Pharmacol Exp Ther | 1974 | https://conductscience.org/library/papers/4423599 | PubMed |
| 7 | 4593887 | Chemotherapy of systemic mycoses (first of two parts). | N Engl J Med | 1974 | https://conductscience.org/library/papers/4593887 | PubMed |
| 8 | 4987171 | The effect of diphenylhydantoin on thyroxine metabolism in man. | J Clin Invest | 1970 | https://conductscience.org/library/papers/4987171 | PubMed |
| 9 | 5110737 | Increased permeability of human erythrocytes induced by amphotericin B. | J Infect Dis | 1971 | https://conductscience.org/library/papers/5110737 | PubMed |
| 10 | 5456013 | Amphotericin B serum concentrations during therapy. | Appl Microbiol | 1970 | https://conductscience.org/library/papers/5456013 | PubMed |
| 11 | 5819291 | Pharmacokinetics of intrathecally administered amphotericin B. | Am Rev Respir Dis | 1969 | https://conductscience.org/library/papers/5819291 | PubMed |
| 12 | 5672740 | Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. | Am J Med | 1968 | https://conductscience.org/library/papers/5672740 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984876 | Pharmacokinetic and pharmacodynamic strategies to optimize antifungal therapy, prevent resistance and minimize treatment failure. | JAC Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42984876 | PubMed |
| 40381011 | Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40381011 | PubMed |
| 35064965 | Berkeley Madonna Version 10-A simulation package for solving mathematical models. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35064965 | PubMed |
| 34065929 | Macrolides: From Toxins to Therapeutics. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34065929 | PubMed |
| 33523419 | Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections. | Infect Dis Ther | 2021 | https://conductscience.org/library/papers/33523419 | PubMed |
| 31551999 | Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31551999 | PubMed |
| 30056571 | Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major. | J Mater Sci Mater Med | 2018 | https://conductscience.org/library/papers/30056571 | PubMed |
| 28702763 | Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. | Infection | 2017 | https://conductscience.org/library/papers/28702763 | PubMed |
| 28480108 | Fungal brain abscess caused by "Black Mold" (Cladophialophora bantiana) - A case report of successful treatment with an emphasis on how fungal brain abscess may be different from bacterial brain abscess. | Surg Neurol Int | 2017 | https://conductscience.org/library/papers/28480108 | PubMed |
| 27821250 | Antifungal pharmacodynamics: Latin America's perspective. | Braz J Infect Dis | 2017 | https://conductscience.org/library/papers/27821250 | PubMed |
| 26349818 | Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26349818 | PubMed |
| 24872147 | Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications. | Drugs | 2014 | https://conductscience.org/library/papers/24872147 | PubMed |
| 24595533 | Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/24595533 | PubMed |
| 24456292 | Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri. | CNS Neurosci Ther | 2014 | https://conductscience.org/library/papers/24456292 | PubMed |
| 21854638 | In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines. | Lipids Health Dis | 2011 | https://conductscience.org/library/papers/21854638 | PubMed |
| 21431453 | Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data. | AAPS J | 2011 | https://conductscience.org/library/papers/21431453 | PubMed |
| 20540940 | Flow cytometric screening for anti-leishmanials in a human macrophage cell line. | Exp Parasitol | 2010 | https://conductscience.org/library/papers/20540940 | PubMed |
| 19741525 | Pediatric antifungal agents. | Curr Opin Infect Dis | 2009 | https://conductscience.org/library/papers/19741525 | PubMed |
| 15101785 | Antifungals in systemic neonatal candidiasis. | Drugs | 2004 | https://conductscience.org/library/papers/15101785 | PubMed |
| 11850268 | Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11850268 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/646348
GET https://conductscience.org/api/papers/v1/646348/cited_by?page=2